FLASH is a form of radiotherapy that is delivered ultra-rapidly at a very high dose/time ratio. FLASH is not used in clinical practice, but this type of radiotherapy is currently being developed and tested. The hope is to be able to apply more radiation but with less damage to normal

My goal is to develop a computational workflow that uses public datasets and protein structure models to identify conserved, surface-exposed, and functionally important bacterial antigens for vaccine design. This workflow will generate the most comprehensive resource for rational vaccine development against antimicrobial-resistant pathogens. By designing and testing optimised vaccines, I

I have already developed a new unique treatment for lung emphysema in COPD patients and obtained very promising in vitro results. In line with these, I expect to observe that the Lung-bioECM promotes the regeneration of the damaged lung tissue in a relevant animal model of emphysema. This will motivate

Our team at Dhalion Biotech, a recently founded spin-off from Lund University, developed a method for generating human mini bones for preclinical studies. These miniaturized bone and bone marrow organs are established under the skin in research animals (i.e. mice) non-invasively using our product, OssiGel. This is an off-the-shelf human

The study has the potential to enable tailored treatment for depression. If the results are positive, pramipexole could be introduced as an alternative for depressed patients. There are several other ongoing or planned studies investigating similar hypotheses, namely that pramipexole may serve as a tailored treatment for anhedonia. If several

The project aims to identify biomarkers in STBEVs that can be used to improve diagnosis and prognosis of pre-eclampsia. By identifying the specific molecular signatures of the disease, we can develop methods for personalised risk assessment and earlier intervention, which can reduce the impact of the disease and improve clinical

We are developing objective and quantitative assessment tools that measure cerebellar function in combination with a modernised movement assessment test. We believe this has the potential to revolutionise the way we assess and study ADHD and ASD – two diagnoses that affect several hundred thousand children in Sweden alone. In

A large international study on ~8000 individuals from 8 countries followed for up to 20 years revealed biomarker to predict diabetes. Based on the discovery, LDcoder® was develop at Lundoch Diagnostics, which efficiently predicts the risk of diabetes at least four year before the disease actually develops. In this project,

We want to make a significant difference to the lives of people with PD and their families. Our specific aim is to verify and patent a new technology for the treatment of PD. Our technology (adaptive DBS) makes it possible to adapt the treatment to the individual’s changing needs, which

The glymphatic system is fundamental to the understanding of common diseases from multiple sclerosis to dementia. Currently, there is no non-invasive method to track the clearance of brain metabolites by the glymphatic system and thus link preclinical research with clinical research in this area. This work is the first time